NEJM published first CTX001 CRISPR patient cases for sickle cell and β-thalassemia
Dated 5 December 2020: NEJM published first CTX001 CRISPR patient cases for sickle cell and β-thalassemia. In the causal graph this event strengthens the driver Gene-Editing Diffusion.
Who was responsible
Contribution type and responsibility level for each recorded actor — not sole-author shorthand.
No public contributors are listed for this fact.
What changed
Fact → Driver → Indicator. Relationship strength orders the paths; it is not the observed indicator movement.
- FactNEJM published first CTX001 CRISPR patient cases for sickle cell and β-thalassemia
- strengthensDriverGene-Editing Diffusion
provisional weight · verified
Causal path
How this event connects to drivers and indicators in the graph.
- FactNEJM published first CTX001 CRISPR patient cases for sickle cell and β-thalassemia
- strengthensDriverGene-Editing Diffusion
Cite this page
Factrail. (2026). NEJM published first CTX001 CRISPR patient cases for sickle cell and β-thalassemia. Factrail. https://factrail.ai/facts/frangoul-nejm-ctx001-sickle-thalassemia-december-2020
https://factrail.ai/facts/frangoul-nejm-ctx001-sickle-thalassemia-december-2020
Accessed 16 October 2026.
By the Factrail desk · Method: how we source and score · Last reviewed
Dispute this factNamed here, or represent someone who is? Request a right of reply.